Combined assessment of Epstein–Barr virus viral capsid antigen and Epstein–Barr virus nuclear antigen‐1 serology for post‐transplant lymphoproliferative disorder risk stratification in adult solid organ transplant recipients-Reference-Cited by-同舟云学术

Combined assessment of Epstein–Barr virus viral capsid antigen and Epstein–Barr virus nuclear antigen‐1 serology for post‐transplant lymphoproliferative disorder risk stratification in adult solid organ transplant recipients

Published:2022-09-06 Issue:6 Volume:24 Page:
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transplant Infectious Dis

Author:

Heldman Madeleine R.¹²^ORCID,Edlefsen Kerstin L.³,Pepper Gregory³,Kapnadak Siddhartha G.⁴,Rakita Robert M.¹^ORCID,Fisher Cynthia E.¹,Limaye Ajit P.¹³

Affiliation:

1. Division of Allergy and Infectious Diseases, Department of Medicine University of Washington Seattle Washington USA

2. Vaccine and Infectious Disease Division Fred Hutchinson Cancer Center Seattle Washington USA

3. Department of Laboratory Medicine and Pathology University of Washington Seattle Washington USA

4. Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine University of Washington Seattle Washington USA

Funder

National Institute of Allergy and Infectious Diseases

National Heart, Lung, and Blood Institute

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tid.13933

Reference30 articles.

1. Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients

2. Post-Transplantation Lymphoproliferative Disorders in Adults

3. Post‐transplant lymphoproliferative disorders, Epstein‐Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer Surveillance in Solid Organ Transplant Recipients With a Pretransplant History of Malignancy: Multidisciplinary Collaborative Expert Opinion;Transplantation;2024-05-21

2. Recent Advances in Adult Post-Transplant Lymphoproliferative Disorder;Cancers;2022-12-01